Keywords: az, gets, nod, eu, new, atacand, doses
AZ gets nod in EU for two new Atacand doses
Article | 16 February 2009
Anglo-Swedish drug major AstraZeneca has received European approval for two new dose strengths of its the angiotensin receptor blocker Atacand ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
